News
The Proteus Syndrome market is entering a pivotal decade, driven by increasing disease recognition, improving diagnostic techniques, development of genetic testing techniques and other innovative ...
The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...
8d
Zacks Investment Research on MSNRegeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock ...
Regeneron Pharmaceuticals has recently launched a Phase 2 trial, testing the waters with a potential breakthrough in melanoma ...
The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and ...
Key factors fueling this trend include increased awareness, improved healthcare infrastructure, and enhanced diagnostic and treatment accessibility. With the prevalence of high myopia projected to ...
Unifying Bangladesh’s investment landscape: Why BSCIC is indispensable for inclusive growth and global competitiveness Executive Summary: A Call for Strategic Inclusion Bangladesh stands on the cusp ...
Power your summer with an EV! Discover MINI's competitive July lease offer on the 2025 Countryman EV, blending iconic style, all-electric performance, and attractive monthly payments.
SACRAMENTO—The Bureau of Land Management (BLM) is set to conduct a competitive geothermal lease sale on Tuesday, August 26, 2025. This sale will feature 13 parcels encompassing a total of 23,000 acres ...
$30,000 of REGENERON PHARMACEUTICALS INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results